A series of fusions using mouse myeloma cells and spleen cells from mice
immunized with blood group substances or human red cells was performed with the aim of
obtaining ABO antibodies suitable for routine blood grouping. Seven strongly agglutinating
antibodies against antigens in the ABO system were obtained from 18 fusions. These antibodies
were tested extensively in manual and automated routines, and six of them were
found to be as good as or better than commercial polyclonal test sera of human origin.
A haemagglutinating monoclonal anti-Le^bL antibody has been obtained from a
mouse-mouse hybridoma after immunization with the Leb-active oligosaccharide lacto-
N-difucohexaose I, coupled to edestin. Of 13 other antibodies obtained, one was able to
agglutinate enzyme-treated erythrocytes of all ABO groups and three more were considered
to be anti-Le^bH haemagglutinins. The remaining nine antibodies did not agglutinate red
cells. The specificity of the stronger of the anti-Le^bL haemagglutinins was examined by
studying its binding to a number of glycoconjugates and oligosaccharides.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.